ACM
TEVA icon

Antonetti Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Antonetti Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$8.7K Hold
853
– – 0.01% 217
2023
Q2 		$6.42K Hold
853
– – 0.01% 241
2023
Q1 		$7.55K Hold
853
– – 0.01% 238
2022
Q4 		$7.78K Hold
853
– – 0.01% 236
2022
Q3 		$7K Hold
853
– – 0.01% 244
2022
Q2 		$6K Hold
853
– – 0.01% 258
2022
Q1 		$8K Hold
853
– – 0.01% 272
2021
Q4 		$7K Sell
853
-2,800
-77% -$25.3K 0.01% 320
2021
Q3 		$36K Buy
+3,653
New +$34.2K 0.03% 186
2014
Q3 		– Sell
-135
Closed -$7K – 200
2014
Q2 		$7K Sell
135
-533
-80% -$27.2K 0.01% 167
2014
Q1 		$35K Hold
668
– – 0.03% 130
2013
Q4 		$27K Hold
668
– – 0.02% 157
2013
Q3 		$25K Hold
668
– – 0.03% 195
2013
Q2 		$26K Buy
+668
New +$26K 0.03% 198

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Antonetti Capital Management's TEVA Position: Q3 2023 in Review

Antonetti Capital Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q3 2023 at 853 shares worth $8.7K. The position accounts for 0.01% of the portfolio, ranked #217.

Antonetti Capital Management first reported a position in TEVA in Q2 2013 and has held it in 14 quarters since. The position peaked at $36K in Q3 2021. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • Antonetti Capital Management held 853 shares of Teva Pharmaceutical Industries Limited worth $8.7K as of Q3 2023.
  • Antonetti Capital Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q3 2023.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Antonetti Capital Management's portfolio in Q3 2023, its #217 holding.
  • Antonetti Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 14 quarters since.
  • Antonetti Capital Management's Teva Pharmaceutical Industries Limited position peaked at $36K in Q3 2021.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.